All SEC Filings :: Ligand Pharmaceuticals Incorporated (LGND)

Filter Filings:

Date	Form	Description	Docs	XBRL	Pages
01/27/21	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			5
01/15/21	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			5
01/13/21	UPLOAD	SEC-generated letter Related Documents TEXT-EXTRACT			1
01/06/21	CORRESP	A correspondence can be sent as a document with another submission type or can be sent as a separate submission.			4
01/05/21	4	Statement of changes in beneficial ownership of securities			2
12/23/20	UPLOAD	SEC-generated letter Related Documents TEXT-EXTRACT			3
12/21/20	8-K	Current report filing Related Documents EX-99.1			7
12/16/20	8-K	Current report filing			5
12/10/20	8-K/A	Current report filing Related Documents EX-23.1 EX-99.1 EX-99.2			49
12/09/20	4	Statement of changes in beneficial ownership of securities			2